Dhuria S - Search Results

1

Ribociclib Bioavailability Is Not Affected by Gastric pH Changes or Food Intake: In Silico and Clinical Evaluations.

Samant TS, Dhuria S, Lu Y, Laisney M, Yang S, Grandeury A, Mueller-Zsigmondy M, Umehara K, Huth F, Miller M, Germa C, Elmeliegy M. Samant TS, et al. Among authors: dhuria s. Clin Pharmacol Ther. 2018 Aug;104(2):374-383. doi: 10.1002/cpt.940. Epub 2017 Dec 8. Clin Pharmacol Ther. 2018. PMID: 29134635 Free PMC article. Clinical Trial.

2

Ribociclib Drug-Drug Interactions: Clinical Evaluations and Physiologically-Based Pharmacokinetic Modeling to Guide Drug Labeling.

Samant TS, Huth F, Umehara K, Schiller H, Dhuria SV, Elmeliegy M, Miller M, Chakraborty A, Heimbach T, He H, Ji Y. Samant TS, et al. Among authors: dhuria sv. Clin Pharmacol Ther. 2020 Sep;108(3):575-585. doi: 10.1002/cpt.1950. Epub 2020 Jul 25. Clin Pharmacol Ther. 2020. PMID: 32557601 Clinical Trial.

3

Ribociclib plus letrozole in early breast cancer: A presurgical, window-of-opportunity study.

Curigliano G, Gómez Pardo P, Meric-Bernstam F, Conte P, Lolkema MP, Beck JT, Bardia A, Martínez García M, Penault-Llorca F, Dhuria S, Tang Z, Solovieff N, Miller M, Di Tomaso E, Hurvitz SA. Curigliano G, et al. Among authors: dhuria s. Breast. 2016 Aug;28:191-8. doi: 10.1016/j.breast.2016.06.008. Epub 2016 Jun 20. Breast. 2016. PMID: 27336726 Free article. Clinical Trial.

4

Time-dependent inhibition and induction of human cytochrome P4503A4/5 by an oral IAP antagonist, LCL161, in vitro and in vivo in healthy subjects.

Dhuria S, Einolf H, Mangold J, Sen S, Gu H, Wang L, Cameron S. Dhuria S, et al. J Clin Pharmacol. 2013 Jun;53(6):642-53. doi: 10.1002/jcph.79. Epub 2013 Apr 15. J Clin Pharmacol. 2013. PMID: 23585187

5

No Effect of Plazomicin on the Pharmacokinetics of Metformin in Healthy Subjects.

Choi T, Komirenko AS, Riddle V, Kim A, Dhuria SV. Choi T, et al. Among authors: dhuria sv. Clin Pharmacol Drug Dev. 2019 Aug;8(6):818-826. doi: 10.1002/cpdd.648. Epub 2019 Jan 3. Clin Pharmacol Drug Dev. 2019. PMID: 30605260 Clinical Trial.

6

Phase I dose-escalation study of LCL161, an oral inhibitor of apoptosis proteins inhibitor, in patients with advanced solid tumors.

Infante JR, Dees EC, Olszanski AJ, Dhuria SV, Sen S, Cameron S, Cohen RB. Infante JR, et al. Among authors: dhuria sv. J Clin Oncol. 2014 Oct 1;32(28):3103-10. doi: 10.1200/JCO.2013.52.3993. Epub 2014 Aug 11. J Clin Oncol. 2014. PMID: 25113756 Clinical Trial.

7

Intranasal delivery to the central nervous system: mechanisms and experimental considerations.

Dhuria SV, Hanson LR, Frey WH 2nd. Dhuria SV, et al. J Pharm Sci. 2010 Apr;99(4):1654-73. doi: 10.1002/jps.21924. J Pharm Sci. 2010. PMID: 19877171 Review.

8

Novel vasoconstrictor formulation to enhance intranasal targeting of neuropeptide therapeutics to the central nervous system.

Dhuria SV, Hanson LR, Frey WH 2nd. Dhuria SV, et al. J Pharmacol Exp Ther. 2009 Jan;328(1):312-20. doi: 10.1124/jpet.108.145565. Epub 2008 Oct 22. J Pharmacol Exp Ther. 2009. PMID: 18945930

9

Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system.

Dhuria SV, Hanson LR, Frey WH 2nd. Dhuria SV, et al. J Pharm Sci. 2009 Jul;98(7):2501-15. doi: 10.1002/jps.21604. J Pharm Sci. 2009. PMID: 19025760

10

Food consumption and activity levels increase in rats following intranasal Hypocretin-1.

Dhuria SV, Fine JM, Bingham D, Svitak AL, Burns RB, Baillargeon AM, Panter SS, Kazi AN, Frey WH 2nd, Hanson LR. Dhuria SV, et al. Neurosci Lett. 2016 Aug 3;627:155-9. doi: 10.1016/j.neulet.2016.05.053. Epub 2016 Jun 2. Neurosci Lett. 2016. PMID: 27264485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters